Beta carotene inhibiting HIV-1 reverse transcriptase, an in silico approach
- Title
- Beta carotene inhibiting HIV-1 reverse transcriptase, an in silico approach
- Creator
- Nag A.; Reema D.
- Description
- Due to the outspread of various emerging diseases, research on the discovery of new drugs is being carried out extensively. Several phytochemicals with medicinal importance are now being used for this purpose due to its effectiveness and safety in comparison to the conventional synthetic ones. Computational docking is further being used for the fast and cost-effective screening. Reverse transcriptase is a key enzyme involved in the conversion of viral RNA sequence into complementary DNA (cDNA) sequence leading to various retroviral diseases like HIV/AIDS. Patchdock docking server was used in this study to perform in silico enzyme-inhibitor binding experiment between twenty phytocompounds and HIV-1 reverse transcriptase enzyme. Beta-carotene was found to have strongest binding potential in comparison to other phytochemicals. The results suggested that this compound can be used as therapeutics in the future as naturally occurring HIV-1 reverse transcriptase inhibitor. 2020 World Research Association. All rights reserved.
- Source
- Research Journal of Biotechnology, Vol-15, No. 1, pp. 69-73.
- Date
- 2020-01-01
- Publisher
- World Research Association
- Subject
- Beta-carotene; Docking; In silico; Phytochemicals; Reverse transcriptase
- Coverage
- Nag A., CHRIST (Deemed to be University), Bangalore, 560029, India; Reema D., CHRIST (Deemed to be University), Bangalore, 560029, India
- Rights
- Restricted Access
- Relation
- ISSN: 9736263
- Format
- Online
- Language
- English
- Type
- Article
Collection
Citation
Nag A.; Reema D., “Beta carotene inhibiting HIV-1 reverse transcriptase, an in silico approach,” CHRIST (Deemed To Be University) Institutional Repository, accessed February 25, 2025, https://archives.christuniversity.in/items/show/16479.